Find latest Skin videos · 300+ videos
Stanford Medicine
A

Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma

By Stanford Medicine FEATURING Amanda Kirane
By Stanford Medicine FEATURING Amanda Kirane
30 views
May 23, 2024
Comments 0
Login to view comments. Click here to Login

Related Videos

09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

499 views
17:01

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

324 views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

857 views
19:31

New

Year in Review 2024 - Key Updates in Melanoma Treatment

Oncology 2024 Year in Review

T. Haykal

175 views
36:27

The Latest and Greatest in Melanoma Treatment, 2024: From Adjuvant t…

Melanoma Research Foundation

K. Margolin

145 views
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

772 views
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

225 views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

830 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

548 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views

Updated in The Treatment of Immune-Related Adverse Events of Immunot…

Cleveland Clinic Dermatology & Plastic Surgery Institute

L. Korb Ferris

194 views
10:37

Understanding Treatment Sequencing in Metastatic Melanoma: IO vs. Ta…

Vanderbilt University Medical Center (VUMC)

D. Johnson

290 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

61 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

336 views
09:50

Overview of Adjuvant and Metastatic Landscape and Immunotherapy Toxi…

Ricky Frazer

273 views
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

291 views
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

416 views
10:40

ESMO 2024 Insights: Survival Impact of Adjuvant Treatment in Stage I…

2024 ESMO Annual Meeting Insights Hub

H. Helgadottir

120 views
18:24

The Role of Tumor Immune Microenvironment and Biomarkers in Melanoma

Yvonne Saenger

91 views
16:05

Adjuvant and Neoadjuvant Advances in Stage 3 Melanoma: Insights From…

Penn Medicine Abramson Cancer Center

T. Mitchell

49 views
AUTOPLAY